(Q66064988)
Statements
A Phase 4, Observational Field Study to Evaluate the Safety and Clinical Benefit of TPOXX (Tecovirimat)-Treated Patients Following Exposure to Variola Virus and Clinical Diagnosis of Smallpox Disease (English)
0 references
30 September 2019
0 references
30 September 2024
0 references
100
0 references